Once-weekly basal ultralong-acting insulin administration in type 2 diabetes: a therapy concept for the future?
Crossref DOI link: https://doi.org/10.1007/s11428-023-01117-1
Published Online: 2023-11-09
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schürfeld, Robin
Text and Data Mining valid from 2023-11-09
Version of Record valid from 2023-11-09
Article History
Accepted: 27 October 2023
First Online: 9 November 2023
Interessenkonflikt
: R. Schürfeld gibt an, dass kein Interessenkonflikt besteht.